Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
684.5 CHF | -1.23% | -2.83% | +40.38% |
Jul. 16 | Aclaris Therapeutics Sells Olumiant Royalties, Milestone Payments From Eli Lilly | MT |
Jul. 16 | Goldman Sachs Adjusts Price Target on Eli Lilly to $812 From $793 | MT |
- Stock Market
- Equities
- LLY Stock
- LLY Stock
- News Eli Lilly and Company
- Other languages